Neurotronic, Inc. announced the first clinical outcomes of the NECTAR III and NECTAR IV trials evaluating the company’s ...
Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback